Koushik Prasad advises clients on their highest stakes capital raisings and M&A transactions.
Dual-qualified in the UK and India, Koushik leverages his international perspective and experience working on some of the most complex equity raises in the market to represent companies and investment banks in:
Initial public offerings (IPOs), follow-on offerings, and other capital raisings
Mergers and acquisitions
Joint ventures and strategic investments
In addition, he regularly guides clients on the unique complexities that UK companies face when seeking a listing in the US.
Koushik also helps companies navigate general corporate law, including compliance with the listing rules, disclosure obligations, market abuse regulations, and other regulatory requirements, as well as investment banks in connection with their regulatory obligations and procedures requirements.
A recognized leader at the firm, Koushik serves as Co-Leader of the London LGBTQ+ Affinity Group and as a member of the Training and Career Enhancement (TACE) Committee.
He maintains an active pro bono practice, including providing legal services to Cancer Research UK, as well as structuring and corporate governance advice to various charities, including Killed Women, Crisis Action, and OneTech.
Before joining Latham, Koushik worked in the corporate department of another international law firm in London. He also draws from his secondment at Numis, where he advised the corporate broking and transactions team on the legal aspects of equity capital markets, corporate broking, and M&A transactions.
Experience
Koushik’s experience includes advising:
Capital Markets
The Public Investment Fund (PIF) on its:
Follow-on investment in the £216 million capital raise by way of placing by Aston Martin Lagonda Global Holdings
Proposed strategic investment in the £653 million capital raise by way of firm placing and rights issue by Aston Martin Lagonda Global Holdings
Diversified Energy Company on its:
Additional listing of shares on the New York Stock Exchange
US$163 million cash placing and retail offer to partially finance the acquisition of certain upstream assets and related infrastructure in its Central Region from Tanos Energy Holdings II
US$225 million capital raise by way of a cash box placing
Transfer from the AIM Market to the Main Market (Premium Segment) of the London Stock Exchange and its US$86 million placing
Darktrace on its:
£1.7 billion initial public offering (IPO) and listing on the London Stock Exchange
£25 million post-IPO secondary placing via an accelerated bookbuilt offering
The underwriters on Deliveroo Holdings’ £7.59 billion IPO and listing on the London Stock Exchange
Ortho Clinical Diagnostics on its US$1.3 billion IPO and listing on NASDAQ
J.P. Morgan and Numis, as joint bookrunners, on the £450 million placing of shares by The Unite Group plc
J.P. Morgan as sponsor to Synthomer plc on the Class 1 disposal of its £200 million laminates, films and coated fabrics business
Barclays as sponsor to Capita PLC on the Class 1 disposal of its £207 million software solutions business
Merrill Lynch International, Deutsche Numis and J.P. Morgan Cazenove on the tender offer by Ascential plc to acquire up to £300 million of ordinary shares, as part of the intention to return £850 million to their shareholders
Merrill Lynch International and Investec Bank, as joint bookrunners, on ITM Power’s £250 million placing via an accelerated bookbuilt offering
Morgan Stanley and Numis, as joint bookrunners, on the £51.2 million placing of shares by YouGov, an internet-based market research and data analytics firm, to finance its acquisition of GfK’s consumer panel business
Credit Suisse Group AG on selling its 8.6% stake in Allfunds Group via an accelerated bookbuilt offering for €334 million
The sponsor, joint global coordinators, and joint bookrunners on Aston Martin Lagonda Global’s £125 million capital raise, listed on the London Stock Exchange and strategic cooperation with Mercedes-Benz
The joint global coordinators and joint bookrunners on the £116 million cash placing by S4 Capital plc, the digital advertising and marketing services company
The joint global coordinators, bookrunners, and managers on Zealand Pharma’s US$100 million placement in 2020 and US$122 million placement in 2021
The underwriters on the £2.4 billion IPO of Avast, the world’s largest consumer antivirus software supplier, listed on the London Stock Exchange
DNEG, the international visual effects company, on its proposed IPO on the London Stock Exchange
Bain Capital on its £157 million block trade sale of equity shares in TI Fluid
The principal creditors of Aegerion Pharmaceuticals on the reverse takeover of Aegerion by Amryt Pharma, an AIM-listed company in the UK in connection with Aegerion’s chapter 11 bankruptcy and reorganization petition in the US
M&A and Joint Ventures
Lithia Motors on acquiring the UK motor and leasing business of UK premium listed Pendragon, its joint venture with Pendragon in North America as part of a strategic partnership, and £30 million subscription for shares in Pendragon by way of a non-pre-emptive issuance
Zapp Electric Vehicles, a UK-based, high-performance two-wheel electric vehicle company, on its business combination with CIIG Capital Partners II, a special-purpose acquisition company
The sole sponsor and joint financial adviser on EVRAZ’s potential demerger of its metallurgical coal business
ReNew Power on its US$8 billion merger with RMG Acquisition Corporation II and subsequent listing on NASDAQ
Total SA on its natural gas distribution joint venture with Adani Group, created via Total’s acquisition of 37.4% of Adani Gas Limited, an Indian public company
A global financial technology company on its pre-IPO corporate reorganization
Qualifications
Bar Qualification
England and Wales (Solicitor)
Education
MBA, University of Oxford, 2015
BA LLB (Honours), National Law School of India University, 2010
Firm honored by Law360 for advising startups, financial institutions, VCs, digital asset and Web3 participants, and corporations on their most innovative and complex transactions, investigations, litigation, and regulatory matters.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.